Oncology & Cancer

Pill halves risk of death in type of lung cancer

A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.

Medical research

How hepatitis E viruses enter cells

Although hepatitis E is a common disease, little is known about the life cycle of the virus. Initial findings on how it manages to infect cells are reported by a team from Molecular and Medical Virology at Ruhr University ...

page 2 from 20